Evaluation of Varicella Zoster Virus specific immune response assessed by IFN-g releasing assay

Evaluation of Varicella Zoster Virus specific immune response assessed by IFN-g releasing assay - Varicella Zoster Virus specific immune response assessed by IFN-g releasing assay

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018695

Enrollment

Registered

2015-08-17

Start date

2015-08-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adult, 20 to 75 years of age

Interventions

varicella vaccine live attenuated &quot

BIKEN&quot

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy adults, male or female

Exclusion criteria

Exclusion criteria: Vaccination inappropriate person : A person under any of the following condition is not able to be vaccinated. 1. A person who has a fever 2. A person appear suffering severe acute illness 3. A person who previously exhibited anaphylaxis by components of this varicella vaccine 4. A pregnant woman 5. In addition to the persons listed above, a person who is in an inappropriate state for vaccination

Design outcomes

Primary

Measure	Time frame
rate of change of IFN-g after vaccination of varicella vaccine	—

Countries

Japan

Contacts

Public ContactAtsuko Hata

The Tazuke Kofukai Medical Research Institute Department of Infectious Diseases

infe@kitano-hp.or.jp06-6131-2889

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026